Silencing expression of ribosomal protein L26 and L29 by RNA interfering inhibits proliferation of human pancreatic cancer PANC-1 cells (Q39301495)

10 September 2017

title

Silencing expression of ribosomal protein L26 and L29 by RNA interfering inhibits proliferation of human pancreatic cancer PANC-1 cells (English)

1 reference

10 September 2017

1 reference

Chaodong Li

1

1 reference

10 September 2017

Mei Ge

2

1 reference

10 September 2017

Yu Yin

3

1 reference

10 September 2017

Minyu Luo

4

1 reference

10 September 2017

Daijie Chen

5

1 reference

10 September 2017

publication date

7 August 2012

1 reference

Molecular and Cellular Biochemistry

10 September 2017

published in

1 reference

10 September 2017

volume

370

1 reference

10 September 2017

issue

1-2

1 reference

10 September 2017

page(s)

127-139

1 reference

Increasing complexity of Ras signaling.

10 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11010-012-1404-X

ras GTPase activating protein: signal transmitter and signal terminator

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-012-1404-X

21 January 2018

Focus on pancreas cancer

1 reference

https://api.crossref.org/works/10.1007%2FS11010-012-1404-X

21 January 2018

Cancer statistics, 2005

1 reference

https://api.crossref.org/works/10.1007%2FS11010-012-1404-X

Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-012-1404-X

Dual knockdown of N-ras and epiregulin synergistically suppressed the growth of human hepatoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-012-1404-X

Tumour stem cells and drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-012-1404-X

Mechanisms of cancer drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-012-1404-X

Molecular consequences of silencing mutant K-ras in pancreatic cancer cells: justification for K-ras-directed therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-012-1404-X

Growth factor receptors and related signalling pathways as targets for novel treatment strategies of hepatocellular cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-012-1404-X

A lentiviral RNAi library for human and mouse genes applied to an arrayed viral high-content screen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-012-1404-X

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-012-1404-X

Synergism of BARF1 with Ras induces malignant transformation in primary primate epithelial cells and human nasopharyngeal epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-012-1404-X

Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-012-1404-X

Does the ribosome translate cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-012-1404-X

Many ribosomal protein genes are cancer genes in zebrafish

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-012-1404-X

Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-012-1404-X

Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-012-1404-X

Therapeutic strategies by modulating oxygen stress in cancer and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-012-1404-X

Chemical genetic screening of KRAS-based synthetic lethal inhibitors for pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-012-1404-X

A system for stable expression of short interfering RNAs in mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-012-1404-X

A versatile tool for conditional gene expression and knockdown

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-012-1404-X

Stable suppression of tumorigenicity by virus-mediated RNA interference

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-012-1404-X

Mechanisms of drug resistance in chemotherapy for urogenital carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-012-1404-X

How common are extraribosomal functions of ribosomal proteins?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-012-1404-X

Regulation of p53 translation and induction after DNA damage by ribosomal protein L26 and nucleolin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-012-1404-X

Repression of HIP/RPL29 expression induces differentiation in colon cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-012-1404-X

Heparin/heparan sulfate interacting protein plays a role in apoptosis induced by anticancer drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-012-1404-X

Expression of small interfering RNAs targeted against HIV-1 rev transcripts in human cells

21 January 2018

1 reference

12 December 2020

Combined silencing of K-ras and Akt2 oncogenes achieves synergistic effects in inhibiting pancreatic cancer cell growth in vitro and in vivo

1 reference

12 December 2020

K-ras as a target for cancer therapy

1 reference

12 December 2020

Clinical relevance of the molecular mechanisms of resistance to anti-cancer drugs

1 reference

12 December 2020

Heparin/heparan sulfate interacting protein gene expression is up-regulated in human colorectal carcinoma and correlated with differentiation status and metastasis

1 reference

12 December 2020

10.1007/S11010-012-1404-X

Identifiers

DOI

1 reference

10 September 2017

1 reference